In this podcast, Anne Rose, PharmD, talks about factors associated with increased risk of recurrent VTE, appropriate duration of anticoagulation for VTE depending on risk/benefit analysis,...
In this podcast, Jeffrey Tabas, MD, shares his thoughts on the use of smartwatches and other devices that continuously monitor heart rhythm among patients with atrial fibrillation.
In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, speaks about his research on the association between food insecurity, cardiorenal syndrome, and all-cause mortality among low-income adults in the United...
In this podcast, Parag Goyal, MD, MSc, provides an overview of a new risk calculator and explains how it can play a role in meeting the “need to move toward a more tailored, personalized approach” to...
He talks about the prevalence of sudden cardiac arrest among younger athletes, how to risk stratify this population, and the controversy around using electrocardiogram imaging in standard care.
In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
How do patterns of blood pressure change over the life course and differ between men and women? A new analysis contradicts what you think you know. Lead researcher Susan Cheng, MD, MPH, MMSc, offers her...
Luke Joseph Laffin, MD, from the Cleveland Clinic Foundation, answers our questions about his research on the effect of phase 2 cardiac rehabilitation on exercise capacity and outcomes in patients with...
Andres Pineda Maldonado, MD, from the University of Florida, Jacksonville, answers our questions about new therapies for mitral valve disease, the different recommendations for men vs women, and more.
